FAK Inhibition Emerges as a Potential Complementary Treatment Pathway
Although FAK inhibition alone has displayed modest activity to date, there is interest in developing FAK-targeted therapies for combination regimens.
Although FAK inhibition alone has displayed modest activity to date, there is interest in developing FAK-targeted therapies for combination regimens.
We have noticed an unusual activity from your IP 199.16.157.180 and blocked access to this
A melanoma therapeutic vaccine is a type of personalized cancer vaccine that is intended to train the immune system to fight cancer cells.
Inflammatory breast cancer is a rare, aggressive form of the disease that’s frequently misdiagnosed. Wendy Woodward, M.D., Ph.D., explains why speed and an accurate diagnosis…
Cancer Cytopathology is an international cytopathology journal publishing research related to topics concerning the etiology of cancer, its diagnosis and prevention.
SLS009 plus venetoclax and azacitidine elicited responses in patients with relapsed/refractory AML, particularly in those harboring ASXL1 mutations.
All women should start screening for breast cancer at age 40, with biennial screening continuing through age 74, the U.S. Preventive Services Task Force said…
The Video Journal of Oncology (VJOncology) is an independent, global, open-access video journal, dedicated to providing trusted and up-to-date information in order to improve the…
This ESMO Webinar Series is available to all healthcare professionals working in Oncology.
The OncoAlert Newsletter is now out for June 23-29, 2023
Patients with siNETs metastatic to both the liver and peritoneum have favorable outcomes after aggressive surgical cytoreduction, with the best outcomes observed after complete cytoreduction.…